Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin

NCT03147183 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Infection

Interventions

DRUG: Thymoglobulin

Sponsor

Maimónides Biomedical Research Institute of Córdoba